The synergism of C3 and APOE 4 can potentially increase amyloid deposition and Tau hyperphosphorylation in the cerebrospinal fluid of patients with Alzheimer's disease [30]. Here, C3 is linked to early-onset autosomal dominant Alzheimer disease.